Balance by Quarter Change Q1-2017 Q4-2016 Q1-2016 Q1-2017 vs Q4-2016 Q1-2017 vs Q1- 2016 (MB) (MB) % (MB) % Total Revenue 1,139.2 939.7 1,122.7 199.5 21.2% 16.5 1.5% Total Operating Expenses 960.5 790.6
results for the six-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech
% in previous year to 26.43% due to change in product sales mix of general merchandise and the enhancement of directly sourced private-label goods’ profit margin, as well as the continuous efficiency
transportation costs, the gross profit margin as a percentage of sales has increased from 26.49% in the previous year to 27.10% due to change in product sales mix of general merchandise and the enhancement of
School Name: สารสาสน์วิเทศศึกษา (Translation) Re: BOD.SET 029/2017 August 11, 2017 Subject: Clarification on the Change in operating results for year ended June 30, 2017 over 20% compared with the
School Name: สารสาสน์วิเทศศึกษา (Translation) Re: BOD.SET 036/2017 November 10, 2017 Subject: Clarification on the Change in operating results for nine month ended September 30, 2017 over 20
that the change was caused mainly by the significan transaction as bellows 1/2 1.1 Sales and service income of the company for year 2018 decrease by 59 million baht equivalent 6% from previous year
of the previous year, the net profit for the 3rd quarter and the 9-month periods of 2018 were 6.83 million Baht and 11.59 million Baht, decreased from the same period of the previous year by 0.95
changes as follows: 1. Total revenue from sale of goods in the number of 2,740.44 million Baht was increased by 369.28 million Baht or 15.57% from Q3 of the previous fiscal year. The sale growth rates